Kinase inhibitors - Globe Thesis

Keyword [Kinase inhibitors] Result: 181 - 200 \| Page: 10 of 10
181.	The Clinical Study And The Mechanism On The Reversion Of Acquired Resistance With The First Generation EGRF-TKIs For Advanced NSCLC Patients
182.	Discovery Of Novel Type ? Kinase Inhibitors For Class ? Tyrosine Kinases
183.	Design,Synthesis And Bioactivity Evaluation Of CDK4 Inhibitors And FLT3 Inhibitors
184.	The Study Of Multi-target Tyrosine Kinase Inhibitors To Regulate C-Cbl Gene-mediated Chemoresistance In Acute Myeloid Leukemia Cells
185.	Mitogen-Activated Protein Kinase Inhibitors Increase Sensitivity Of Olaparib-Resistant Ovarian Cancer
186.	Antitumor Activity And Mechanism Of Kinase Inhibitors C0129 And C0198
187.	Proteomics In Non-Small Cell Lung Cancer Patients For Prediction Of Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Chemotherapy
188.	Real-world Study Of Diagnosis,Treatment And Prognosis In Chinses Advanced Lung Cancer Patients With Rare Driver Mutations
189.	Characteristics And Survival In Non-small Cell Lung Cancer Patients Harbored Primary And Acquired EGFR T790M Mutation
190.	Investigation On The Anti-tumor Efficacy And Mechanisms Of Small Molecule Kinase Inhibitors In Non-small Cell Lung Cancer
191.	Metabolism And Clinical Pharmacokinetics Of Some Tyrosine Kinase Inhibitors
192.	Mechanism Of MiR-let-7c Rugulates Cyclin-depedent Kinase Inhibitors 1A In Mouse Spermatogonial Cell Line GC-1spg
193.	The Progress Of The Study On Ph-like Acute Lymphoblastic Leukemia
194.	Retrospective Analysis Of Tyrosine Kinase Inhibitors In The Treatment Of Chronic Myeloid Leukemia
195.	Clinical And Genetic Factors Affecting The Efficacy Of Chronic Myeloid Leukemia In TKIs Era
196.	Screening Of PAK4 Kinase Inhibitors And CZh226,A Novel PAK4 Kinase Inhibitor,Suppresses Migration And Invasion Of Lung Adenocarcinoma Cells
197.	MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
198.	Combining Thalidomide With EGFR Tyrosine Kinase Inhibitors Synergistically Inhibits NSCLC Cells In Vitro And In Vivo
199.	Clinical Study Of "Qing Xuan Fei Re Fa" On The Efficacy Of Skin Rash After Applying EGFR-TKI In Patients With Lung Cancer
200.	Design?Synthesis And Optimization Of RIP1 Kinase Inhibitors That Inhibit Necroptosis
<<First <Prev Next> Last>> Jump to